Log In
Print this Print this

Otezla, apremilast (CC-10004)

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionOral phosphodiesterase-4 (PDE-4) inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4) ; Interleukin-2 (IL-2)
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor; Tumor necrosis factor (TNF) alpha inhibitor; Nitric oxide (NO) synthase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today